A rationally designed drug-like protein interferes with the protein-protein interactions of PCNA, the so-called DNA clamp, offering a new way of hindering DNA replication in fast-proliferating cancer cells.
New technology incorporates a range of useful non-canonical amino acids into proteins made in eukaryotes.
Novel platform for antibiotic discovery looks to overcome problem of antibiotic resistance
Bolstering the immune system is not a new strategy when trying to protect against deadly pathogens, yet for those individuals that are immunocompromised, this...
Agency had asked that an additional clinical study be conducted in relapsed/refractory aggressive NHL.
Partners will develop new drug candidates based on Pieris’ Anticalin® technology platform against an undisclosed target.